Leveragen, Inc., a Boston-based biotechnology company advancing next-generation in vivo antibody discovery, announced today the issuance of a patent in Japan covering core innovations underlying its ...
JPMorgan invests $20B in tech to accelerate AI and digital banking, strengthening its edge vs fintechs. Learn more about JPM stock here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results